leisure time -WSS

leisure time

author：leisure time 2025-09-27 09:53:31 - browse：54755

Adam's take main illustration — Molly Ferguson/STAT

Cytokinetics was founded 26 years ago but has not yet developed a drug successfully to approval. That makes Tuesday’s Food and Drug Administration decision on its treatment for heart failure a big deal — except nearly everyone, even investors who own Cytokinetics — hopes the agency rules against it.

Hoping the FDA rejects the Cytokinetics drug, called omecamtiv mecarbil, is a relatively uncommon, up-is-down, down-is-up situation, but it makes sense in this case because the business and science of the drug are not aligned.

Consider: Cytokinetics shares rose in December when an outside group of experts convened by the FDA to examine omecamtiv’s benefits and risks recommended against the medicine’s approval. On Tuesday, the FDA is most likely to heed that advice and turn down the company’s marketing application.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Statins reduce cardiovascular risk in people living with HIV

explore

entertainment

hotspot

WSS

Where does female orgasm come from? Scientists think they know

Tome Biosciences co

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Men with early prostate cancer can safely opt out of treatment

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

Long Covid research funding gets a major boost from NIH

entertainment

leisure time

hotspot

Peter Hotez and the public health issue of online harassment

Doctors on social media are being harassed and cyberbullied

Trump demands the U.S. pay no more for drugs than other countries … again

Statins reduce cardiovascular risk in people living with HIV

In Memoriam: Notable people who died in 2023

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

In age of alternative facts, a scholarly course on calling out crap

Ebola vaccine can save some who are already sick, per new study

Hepatitis C has a cure — but many Americans still lack access to it

Juul documents reveal insider tactics on political lobbying

Wikipedia

New requirements coming in 2024 for Americans traveling to Europe

4 missing after record

Transgender women dream of pregnancy via uterus transplants

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Having children helps parents live longer, especially after age 80

PrEP can help anyone prevent HIV. Why do so few people take it?

explore

entertainment

hotspot

entertainment